Effect of Ingudi Paste and Jatiphala Paste in Vyanga (Melasma)

Phase 2

• Conditions: Health Condition 1: L819- Disorder of pigmentation, unspecifiedHealth Condition 2: L819- Disorder of pigmentation, unspecified

• Registration Number: CTRI/2021/05/033443
• Lead Sponsor: ational Institute of Ayurveda

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Patients presenting Vyanga as clinical features according to Susruta Samhita.

2. Patients of either sex.

3. Patients of age between 18 - 60 years.

Exclusion Criteria

1. Melasma due to tubercular therapy or malignant cases.

2. Patients having systemic pathogenesis due to allergy.

3. Patients having diagnosis of major illness like IHD, HTN, MI, TB, COPD, DM etc. would be excluded from trial.

4. Diagnosed patients of Carcinoma, Burns, Herpes, Eczema, Psoriasis, Measles, Chickenpox, Leucoderma and Leprosy.

5. Person suffering from any infective or contagious skin disease or under medication with antibiotics, antifungal and steroid.

6. Patients of uncontrolled hormonal disease.

7. Any kind of hereditary skin disorder

8. With present history of pregnancy and chronic constipation.

9. Patient suffering from Melasma more than five year.

10. Patients who are reporting allergy history of trail drugs.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in Melasma Area and Severity Index (MASI). in one month ( 4 week)treatmentTimepoint: Reduction in Melasma Area and Severity Index (MASI). in one month ( 4 week) treatment

Secondary Outcome Measures

Name	Time	Method
Changes in <br/ ><br>face skin colour in 4 weeksTimepoint: Changes in face skin colour in 4 weeks